Cargando…
Intestinal and Peripheral Fibrinogen-Like Protein 2 Expression in Inflammatory Bowel Disease
BACKGROUND: Fibrinogen-like protein 2 (FGL2), a new member of the fibrinogen-like family, has recently been identified as a novel immunosuppressive molecule. AIM: The purpose of this work was to investigate intestinal and peripheral expression of FGL2 in patients with inflammatory bowel disease (IBD...
Autores principales: | Dong, Xiuli, Ye, Xiaohua, Chen, Xiangrong, Chen, Tanzhou, Xie, Saili, Li, Qinfan, Lin, Xiaoxiao, Huang, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087870/ https://www.ncbi.nlm.nih.gov/pubmed/24287641 http://dx.doi.org/10.1007/s10620-013-2962-9 |
Ejemplares similares
-
Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage
por: Chen, Xiao-Fu, et al.
Publicado: (2021) -
Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022) -
Hyperlipemia pancreatitis onset time affects the association between elevated serum triglyceride levels and disease severity
por: Dong, Xiuli, et al.
Publicado: (2022) -
Adenovirus-mediated artificial miRNA targetting fibrinogen-like protein 2 attenuates the severity of acute pancreatitis in mice
por: Ye, Xiaohua, et al.
Publicado: (2017) -
Correlation of fibrinogen-like protein 2 with disease progression in patients with severe acute pancreatitis
por: YE, XIAOHUA, et al.
Publicado: (2014)